I am proud to lead a multinational provider of quality consumer healthcare services in Africa and the Middle East. From a single branch in Egypt in 1979, we now have over 480 points of presence across Egypt, Sudan, Jordan and Nigeria — Africa’s most populous market and our newest expansion territory. We offer more than 2,000 international-standard diagnostics tests. In 2020, we performed over 27 million tests for over 7.1 million patients.
Our success stems from our unwavering commitment to quality and the provision of best-in-class diagnostic services. We are the sole operator of a College of American Pathologists (CAP) accredited facility in Egypt, widely considered the leader in laboratory quality assurance globally. Our investment in our people and in our technology continue to strengthen our brands and help us retain our greatest asset — the loyalty of our patient base.
Looking ahead, I am confident we will continue to capitalize on compelling structural growth drivers in our key markets. These include large, rapidly-growing populations; a high prevalence of lifestyle-related medical conditions; and growing health consciousness among the patient populations we serve.
I am very optimistic about the growth prospects of our Group as we grow in our traditional markets, integrate expansion territories such as Nigeria, and prepare for the launch of new service verticals. As we do so, our goal is simple: To create outstanding value for all of our shareholders and stakeholders — progress on which we will report here, on this website, in real time.
Dr. Hend El Sherbini
Chief Executive Officer